103 related articles for article (PubMed ID: 3496385)
1. Cytotoxic effector function of B lymphoblasts.
Bersani L; Colotta F; Peri G; Mantovani A
J Immunol; 1987 Jul; 139(2):645-8. PubMed ID: 3496385
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor as effector molecule in monocyte mediated cytotoxicity.
Ziegler-Heitbrock HW; Möller A; Linke RP; Haas JG; Rieber EP; Riethmüller G
Cancer Res; 1986 Nov; 46(11):5947-52. PubMed ID: 3756932
[TBL] [Abstract][Full Text] [Related]
3. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor production by human monocytes is a regulated event: induction of TNF-alpha-mediated cellular cytotoxicity by endotoxin.
Kornbluth RS; Edgington TS
J Immunol; 1986 Oct; 137(8):2585-91. PubMed ID: 3760568
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic lymphokines produced by cloned human cytotoxic T lymphocytes. II. A novel CTL-produced cytotoxin that is antigenically distinct from tumor necrosis factor and alpha-lymphotoxin.
Green LM; Reade JL; Ware CF; Devlin PE; Liang CM; Devlin JJ
J Immunol; 1986 Dec; 137(11):3488-93. PubMed ID: 2431035
[TBL] [Abstract][Full Text] [Related]
6. Soluble and membrane-bound TNF-alpha are involved in the cytotoxic activity of B cells from tumor-bearing mice against tumor targets.
Lopez-Cepero M; Garcia-Sanz JA; Herbert L; Riley R; Handel ME; Podack ER; Lopez DM
J Immunol; 1994 Apr; 152(7):3333-41. PubMed ID: 8144919
[TBL] [Abstract][Full Text] [Related]
7. Role of monocyte cytotoxic factor in cytolysis of actinomycin D-treated WEHI 164 cells mediated by freshly isolated human adherent mononuclear blood cells.
Austgulen R; Espevik T; Hammerstrøm J; Nissen-Meyer J
Cancer Res; 1986 Sep; 46(9):4566-70. PubMed ID: 3524816
[TBL] [Abstract][Full Text] [Related]
8. Analysis of cytostatic/cytotoxic lymphokines: relationship of natural killer cytotoxic factor to recombinant lymphotoxin, recombinant tumor necrosis factor, and leukoregulin.
Ortaldo JR; Ransom JR; Sayers TJ; Herberman RB
J Immunol; 1986 Nov; 137(9):2857-63. PubMed ID: 3093586
[TBL] [Abstract][Full Text] [Related]
9. Lipopolysaccharide (LPS) stimulates fresh human monocytes to lyse actinomycin D-treated WEHI-164 target cells via increased secretion of a monokine similar to tumor necrosis factor.
Chen AR; McKinnon KP; Koren HS
J Immunol; 1985 Dec; 135(6):3978-87. PubMed ID: 3905966
[TBL] [Abstract][Full Text] [Related]
10. Analysis of a cytostatic lymphokine produced by incubation of lymphocytes with tumor cells: relationship to leukoregulin and distinction from recombinant lymphotoxin, recombinant tumor necrosis factor, and natural killer cytotoxic factor.
Sayers TJ; Ransom JH; Denn AC; Herberman RB; Ortaldo JR
J Immunol; 1986 Jul; 137(1):385-90. PubMed ID: 2423611
[TBL] [Abstract][Full Text] [Related]
11. Rapid killing of actinomycin D-treated tumor cells by human monocytes. II. Cytotoxicity is independent of secretion of reactive oxygen intermediates and is suppressed by protease inhibitors.
Colotta F; Bersani L; Lazzarin A; Poli G; Mantovani A
J Immunol; 1985 May; 134(5):3524-31. PubMed ID: 4038989
[TBL] [Abstract][Full Text] [Related]
12. Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes.
Peters PM; Ortaldo JR; Shalaby MR; Svedersky LP; Nedwin GE; Bringman TS; Hass PE; Aggarwal BB; Herberman RB; Goeddel DV
J Immunol; 1986 Oct; 137(8):2592-8. PubMed ID: 3760569
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor in human monocyte-mediated antitumor cytotoxicity.
Ziegler-Heitbrock HW; Thiel C; Haas JG; Möller A; Riethmüller G
Nat Immun Cell Growth Regul; 1988; 7(5-6):280-6. PubMed ID: 3221906
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of lymphocyte-mediated cytotoxicity. I. The effects of anti-human lymphotoxin antisera on the cytolysis of allogeneic B cell lines by MLC-sensitized human lymphocytes in vitro.
Ware CF; Granger GA
J Immunol; 1981 May; 126(5):1919-26. PubMed ID: 6452481
[TBL] [Abstract][Full Text] [Related]
15. Major histocompatibility complex-unrestricted cytolytic activity of human T cells. Analysis of precursor frequency and effector phenotype.
Patel SS; Thiele DL; Lipsky PE
J Immunol; 1987 Dec; 139(11):3886-95. PubMed ID: 3500232
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic activities of recombinant soluble murine lymphotoxin-alpha and lymphotoxin-alpha beta complexes.
Mackay F; Bourdon PR; Griffiths DA; Lawton P; Zafari M; Sizing ID; Miatkowski K; Ngam-ek A; Benjamin CD; Hession C; Ambrose CM; Meier W; Browning JL
J Immunol; 1997 Oct; 159(7):3299-310. PubMed ID: 9317128
[TBL] [Abstract][Full Text] [Related]
17. LY-2+ effectors cytotoxic for syngeneic tumor cells: generation by allogeneic stimulation and by supernatants from mixed leukocyte cultures.
Hurrell SM; Zarling JM
J Immunol; 1983 Aug; 131(2):1017-23. PubMed ID: 6223084
[TBL] [Abstract][Full Text] [Related]
18. Human T cell clones exerting multiple cytolytic activities show heterogeneity in susceptibility to inhibition by monoclonal antibodies.
van de Griend RJ; Giphart MJ; Van Krimpen BA; Bolhuis RL
J Immunol; 1984 Sep; 133(3):1222-9. PubMed ID: 6205072
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous cytotoxicity (SCMC) of normal human lymphocytes against a human melanoma cell line: a phenomenon due to a lymphotoxin-like mediator.
Peter HH; Eife RF; Kalden JR
J Immunol; 1976 Feb; 116(2):342-8. PubMed ID: 1082453
[TBL] [Abstract][Full Text] [Related]
20. Involvement of tumour necrosis factor in monocyte-mediated rapid killing of actinomycin D-pretreated WEHI 164 sarcoma cells.
Bersani L; Colotta F; Mantovani A
Immunology; 1986 Oct; 59(2):323-5. PubMed ID: 3770807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
